- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06625892
Investigating the Related Factors and Outcome of Kinesiophobia and the Effects of Multidimensional Interventions in Cardiac Surgery Patients
March 12, 2025 updated by: Ai-Ling Chang
The primary objective of this two-year research project is to investigate the status of activity fear, its related factors, and prognosis in cardiac surgery patients in the first year.
Subsequently, the study aims to develop a comprehensive intervention strategy combining exercise with cognitive-behavioral approaches tailored for cardiac surgery patients and assess the effectiveness of this intervention on activity fear, prognosis, and quality of life in the second year.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The study uses a convenient sampling method, focusing on patients undergoing cardiac surgery in the cardiac surgery ward of the Central Medical Center.
The first-year research adopts a descriptive, correlational, and repeated-measures design, while the second-year research employs an experimental design.
Participants are randomly assigned to either the experimental or control group.
The experimental group undergoes a 12-week multidimensional interventions, while the control group receives no intervention.
Data are collected through structured questionnaires.
Data collection occurs at discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.
Study Type
Interventional
Enrollment (Estimated)
245
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chang Ai-Ling, Master
- Phone Number: 886-917160905
- Email: 23570@cch.org.tw
Study Contact Backup
- Name: Wan-Ting Huang, PhD
- Phone Number: 886-953860172
- Email: wanting@mail.dyu.edu.tw
Study Locations
-
-
-
Changhua, Taiwan
- Recruiting
- Changhua Christian Hospital
-
Contact:
- Ai-Ling Chang, Master
- Phone Number: 886-917160905
- Email: 23570@cch.org.tw
-
Contact:
- Wan-Ting Huang, PhD
- Phone Number: +886-953860172
- Email: wanting@mail.dyu.edu.tw
-
Contact:
- Wan-Ting Huang, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients received cardiac surgery.
- Aged 18 or above.
- Clear consciousness and able to communicate in Mandarin or Taiwanese.
- Willing and consent to participate after being informed of the study purpose and procedures.
Exclusion Criteria:
- Cognitive impairment,
- Psychiatric disorders, and
- Long-term bedridden patients who rely on others for daily activities.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: the interventions group
The experimental group undergoes a 12-week multidimensional interventions.
|
The study participants will receive cognitive behavior therapy intervention for six weeks, one session per week, 45 minutes each time, and exercise training for twelve weeks, twice sessions per week, 60 minutes each time.
|
|
No Intervention: the control group
the control group receives no intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
kinesiophobia
Time Frame: 1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.
|
Tampa Scale of Kinesiophobia for Heart (TSK Heart) was used for measuring kinesiophobia in this study.
The TSK Heart developed by Bäck et al. (2012), assesses fear of movement in patients with coronary artery disease.
It comprises four dimensions: exercise avoidance, fear of injury, dysfunctional self-perception, and perceived risk of heart problems, with 17 items.
Each item is scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), and items 4, 8, 12, and 16 are reverse scored.
The total score ranges from 17 to 68, with higher scores indicating greater fear of movement.
A TSK Heart score below 37 indicates a low fear of movement, while a score of 37 or higher indicates a high fear of movement.
The scale's intra-class correlation coefficient is 0.83, and its internal consistency (Cronbach's alpha) is 0.78 (Bäck et al., 2012).
|
1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
International Physical Activity Questionnaire (IPAQ)
Time Frame: 1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.
|
This study uses the short form of the Taiwan version of the IPAQ, developed in collaboration with Liu Ying-Mei and the World Health Organization.
It consists of 7 items assessing physical activity over the past week across work, household chores, transportation, and leisure activities, including time and frequency of walking, moderate and vigorous activities, and time spent sitting.
The total physical activity is calculated by multiplying each activity category by its corresponding Metabolic Equivalent (MET), execution time, and activity days.
An IPAQ score below 600 indicates low physical activity, 600-3000 indicates moderate physical activity, and above 3000 indicates high physical activity.
The scale's content validity is 0.994, and its intra-class correlation coefficient is 0.704 (Liou et al., 2008).
|
1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.
|
|
Taiwan Brief Version of the World Health Organization Quality of Life Questionnaire (WHOQOL-BREF)
Time Frame: 1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.
|
Professor Yao Kai-Ping developed this questionnaire after obtaining authorization; this questionnaire assesses the quality of life across four domains: physical health, psychological well-being, social relationships, and environment, with 28 items.
Each item is scored on a 5-point scale.
Scores for each domain are calculated by averaging the scores of the items within that domain and multiplying by 4. Items 3, 4, and 26 are reverse-scored by subtracting the original score from 6. Higher scores indicate a better quality of life.
The internal consistency is 0.91, and the content validity of the domains ranges from 0.51 to 0.64 (Taiwan WHOQOL Group, 2000; Yao Kai-Ping, 2002).
|
1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Wan-Ting Huang, PhD, Da-Yeh University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 14, 2024
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Study Registration Dates
First Submitted
October 2, 2024
First Submitted That Met QC Criteria
October 2, 2024
First Posted (Actual)
October 3, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 12, 2025
Last Verified
October 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 231124
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Diseases Requiring Surgery
-
Tribhuvan University Teaching Hospital, Institute...CompletedCardiac Surgery | Cardiac Surgery Requiring Cardiopulmonary BypassNepal
-
University Hospital Center of MartiniqueCentre Hospitalier Universitaire Dijon; University Hospital, Limoges; Assistance... and other collaboratorsCompletedPatients Requiring Cardiac SurgeryFrance
-
Uppsala University HospitalRecruitingCardiac Surgery Requiring Cardiopulmonary BypassSweden
-
Pengqiang DuCompletedCardiac Surgery Requiring Cardiopulmonary BypassChina
-
Nantes University HospitalCompletedCardiac Surgery Requiring Cardiopulmonary Bypass | Cardiac Surgery Under Extra Corporeal CirculationFrance
-
Centre Hospitalier Universitaire de Saint EtienneCompletedHeparin Antagonization by Protamine in Cardiac Surgery: Pharmacokinetic/Pharmacodynamic Study (PICS)Cardiac Surgery Requiring Extracorporeal CirculationFrance
-
Polychronis AntonitsisCompletedExtracorporeal Circulation | Cardiac Surgery Requiring Cardiopulmonary BypassGreece
-
Heidelberg UniversityNihon Kohden EuropeCompletedCardiac Diseases Requiring SurgeryGermany
-
University Health Network, TorontoNot yet recruitingCardiac Surgery Requiring Cardiopulmonary Bypass
-
Baxter Healthcare CorporationCompletedCardiopulmonary Bypass | Sternotomy | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median SternotomyUnited States
Clinical Trials on the multidimensional interventions
-
Qu ShenThe First Affiliated Hospital of Xiamen UniversityRecruiting
-
Assiut UniversityNot yet recruiting
-
Gazi UniversityCompleted
-
Cairo UniversityMansoura University; Hiroshima UniversityCompletedStroke | Caregiver Burden | Caregiver BurnoutEgypt
-
Huazhong University of Science and TechnologyWuhan No.1 HospitalRecruitingStress, Psychological | Autonomic Nervous System Diseases | Emotional StressChina
-
Sun Yat-sen UniversityPeking University; Chongqing Medical University; Central South University; Tianjin... and other collaboratorsCompleted
-
Regionsenter for barn og unges psykiske helseUllevaal University HospitalCompleted
-
Federal University of Minas GeraisMedical Research Council; University of Southampton; Federal University of the...CompletedDiabetes Mellitus | Arterial HypertensionBrazil
-
Saglik Bilimleri UniversitesiPendik District Health DirectorateCompletedPain | Infant, Newborn, DiseaseTurkey
-
Qu ShenThe First Affiliated Hospital of Xiamen UniversityNot yet recruitingQuality of Life | Rehabilitation | Pilot Study | Colorectal Cancer Survivor